meRfi®-GM
Antibiotic resistance
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Antimicrobial resistant (AMR) bacterial infections represent an escalating global health crisis, expected to cause 10 million deaths annually by 2050. Due to antibiotic resistance, currently, 1.27 million people die from such infections each year.
The resistance of intestinal pathogens to antibiotics varies significantly across different regions. This variation is influenced by local health practices and regulations concerning antibiotic use. Additionally, vaccines developed to protect against these pathogens may not be equally effective worldwide.
Ahmed et al…
References (Sources)
- 19: US Impact on antimicrobial resistance, special report 2022
- A metabolomics pipeline highlights microbial metabolism in bloodstream infections
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- Next-generation precision antimicrobials: towards personalized treatment of infectious diseases
- Prevalence of antibiotic prescription in southern Italian outpatients: Real-world data analysis of socioeconomic and sociodemographic variables at a municipality level
- The antibiotic resistance crisis: part 1: causes and threats